Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 3 3Phase 2 3Phase 1/2 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 10INDUSTRY 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Prostate Cancer Metastatic 1

Interventions

Carboplatin 273Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 218pembrolizumab 214Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 81Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × XRP6258 × Clear all
NCT01718353 2017-11-20

TAXYNERGY

Sanofi

Phase 2 Completed
63 enrolled 13 charts
Genitourinary

Prostate Cancer Metastatic

NCT01500720 2015-04-13

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Sanofi

Phase 2 Completed
179 enrolled 16 charts
Thoracic

Small Cell Lung Carcinoma

NCT01576029 2013-12-24

SWITCH

Sanofi

Phase 2 Completed
2 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡